Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply

Affiliations

Comment

Otto O Yang et al. N Engl J Med. 2020.

. 2020 Oct 22;383(17):1697-1698.

doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23.

¹ David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA oyang@mednet.ucla.edu.

No abstract available

Comment on

Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
Bölke E, Matuschek C, Fischer JC. Bölke E, et al. N Engl J Med. 2020 Oct 22;383(17):1694-1695. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23. N Engl J Med. 2020. PMID: 32966710 No abstract available.
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
Terpos E, Mentis A, Dimopoulos MA. Terpos E, et al. N Engl J Med. 2020 Oct 22;383(17):1695. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23. N Engl J Med. 2020. PMID: 32966711 No abstract available.
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
Kutsuna S, Asai Y, Matsunaga A. Kutsuna S, et al. N Engl J Med. 2020 Oct 22;383(17):1695-1696. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23. N Engl J Med. 2020. PMID: 32966712 No abstract available.